Non-coding RNA production by RNA polymerase III is implicated in cancer.
RNA polymerase III (Pol III) makes a variety of small non-coding RNAs, such as tRNA and 5S ribosomal RNA. Increased expression of pol III products is often observed in transformed cells. Much progress has been made in determining how Pol III-dependent transcription is regulated and how it increases in cancers, but the importance of this increase has not been clearly established. New evidence suggests that Pol III output can substantially affect transformation.
Marshall
Lynne
L
Beatson Institute for Cancer Research, Bearsden, Glasgow, UK.
White
Robert J
RJ
D000818:Animals; D004195:Disease Models, Animal; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000201:enzymology / Q000235:genetics*; D012320:RNA Polymerase III / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics; D012334:RNA, Neoplasm / Q000235:genetics*; D012341:RNA, Ribosomal, 5S / Q000235:genetics; D012343:RNA, Transfer / Q000235:genetics; D035361:Transcription Factor TFIIIB / Q000235:genetics / Q000378:metabolism; D014158:Transcription, Genetic / Q000235:genetics
D012333:RNA, Messenger; D012334:RNA, Neoplasm; D012341:RNA, Ribosomal, 5S; D035361:Transcription Factor TFIIIB; D012343:RNA, Transfer; D012320:RNA Polymerase III